GALNT4 (Polypeptide N-acetylgalactosaminyltransferase4) participates in initiation and progression of various cancers including colon cancer, non-small cell lung cancer, hepatocellular carcinoma and prostate cancer. Here, GALNT4 is linked to prostate cancer.